Related Experiment Video
Updated: May 22, 2026

Measuring Neural Mechanisms Underlying Sleep-Dependent Memory Consolidation During Naps in Early Childhood
Published on: October 2, 2019
REM Sleep Behavior Disorder as a Key Predictor of Cognitive Decline: Insights from a Narrative Review
1Department of Psychiatry, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Rapid eye movement (REM) sleep behavior disorder (RBD) signals future synucleinopathies like Parkinson's disease. Early identification via neuropsychological testing, imaging, and biomarkers is crucial for managing cognitive decline.
Area of Science:
- Neurology
- Sleep Medicine
- Neurodegenerative Diseases
Background:
- Rapid eye movement (REM) sleep behavior disorder (RBD) is a parasomnia.
- RBD is a prodromal indicator for synucleinopathies, including Parkinson's disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA).
- RBD is significantly linked to progressive cognitive decline in affected individuals.
Purpose of the Study:
- To explore pathophysiological mechanisms linking RBD and cognitive impairment.
- To define the neuropsychological profile of individuals with RBD.
- To evaluate current diagnostic tools and therapeutic challenges for RBD-associated cognitive decline.
Main Methods:
- Synthesized data from clinical cohort studies.
- Utilized structural and functional neuroimaging (MRI, FDG-PET, SPECT).
- Analyzed molecular biomarkers (alpha-synuclein seeding assays) and genetic studies (GBA, SNCA mutations).
Main Results:
- Idiopathic RBD (iRBD) patients show early executive function, attention, visuospatial, and memory deficits.
- Alpha-synuclein aggregate spread correlates with cognitive decline trajectory.
- Neuroimaging reveals cortical thinning and hypometabolism; biomarkers show altered CSF Aβ/tau and positive alpha-synuclein RT-QuIC.
Conclusions:
- Early RBD identification using comprehensive profiling, imaging, and biomarkers is vital for risk stratification.
- Understanding shared pathogenic pathways may lead to targeted neuroprotective strategies.
- Disease-modifying therapies for RBD-associated synucleinopathies are still under development.
More Related Videos
06:23A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice
Published on: September 22, 2020
04:33Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder
Published on: April 26, 2024
Related Concept Videos
REM Sleep Behavior Disorder
RBD is significantly associated with...
Sleepwalking and Sleep Talking
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Understanding Sleep
The circadian rhythm, a nearly 24-hour cycle, is deeply influenced by environmental light cues. Light exposure directly affects the hypothalamus, which in turn regulates...
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Narcolepsy